Peer Coaching for Congenital Heart Disease
(CHASM in ACHD Trial)
Trial Summary
What is the purpose of this trial?
This trial aims to help young adults with congenital heart disease by pairing them with someone who has successfully managed the same condition. This person will offer advice, support, and motivation to help them take better care of themselves and move to adult medical care.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Peer Health Coaching for Congenital Heart Disease?
The research on similar treatments, like e-Health encouragements for adolescents with congenital heart disease, suggests that interactive and motivational support can improve physical fitness and quality of life. This implies that peer health coaching, which also involves support and encouragement, might be effective in promoting better health outcomes for patients with congenital heart disease.12345
Is peer coaching safe for people with congenital heart disease?
Peer coaching, also known as peer support, has been studied in various contexts and is generally considered safe for people with chronic conditions, including those with congenital heart disease. Exercise programs, which can be part of peer coaching, have been shown to be safe for both adults and children with congenital heart disease.46789
How does peer coaching for congenital heart disease differ from other treatments?
Peer coaching for congenital heart disease is unique because it focuses on promoting physical activity and enhancing self-confidence through a supportive, goal-oriented exercise program. Unlike traditional treatments that may focus solely on medical or surgical interventions, this approach emphasizes behavior change, motivation, and self-efficacy to improve overall fitness and quality of life.210111213
Research Team
Richard A Krasuski, MD
Principal Investigator
Duke University
Gary Maslow, MD, MPH
Principal Investigator
Duke University
Eligibility Criteria
This trial is for young adults aged 18-26 with congenital heart disease who are patients at a Duke pediatric cardiology clinic and have access to a smartphone. It's not suitable for individuals with cognitive delays or those attending an adult cardiology clinic.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 6-month peer health coaching intervention or education-only material
Follow-up
Participants are monitored for changes in health-related quality of life, patient activation, self-management, and transition readiness
Long-term follow-up
Evaluate successful transfer of participants from pediatric to adult cardiology care
Treatment Details
Interventions
- Peer Health Coaching
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
Adult Congenital Heart Association
Collaborator